Question 1

What specific type of radiation therapy is being studied in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy clinical trial (NCT01777802). Contact the study team or your healthcare provider for specific answers.

Question 2

How might participating in this study impact my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy clinical trial (NCT01777802). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks and benefits of the radiation therapies being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy clinical trial (NCT01777802). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my immune response be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy clinical trial (NCT01777802). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any side effects I should be aware of from these radiation treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy clinical trial (NCT01777802). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any follow-up care or additional treatments after participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy clinical trial (NCT01777802). Contact the study team or your healthcare provider for specific answers.

What this study is about